As seen in Chain Drug Review
Sitting at the intersection of retail and health care, 2020 and 2021 have been profoundly challenging years for the retail drug store channel.
Read More
The onset of the COVID-19 pandemic had once-in-a-generation impacts across the full business — both pharmacy and retail. On the pharmacy side, there were shifts in chronic versus acute prescription volumes, channel growth in mail-order and delivery, large-scale rollout of COVID-19 testing capabilities, and most recently, a heroic effort to deploy COVID-19 vaccines at scale. On the retail side, we saw store traffic decreases, customer stockpiling pressuring supply chains, explosive e-commerce growth, and highly variable category-level performance driven by changes in consumer behavior.